Search results
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via AOL· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Finance· 7 days agoWhen we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Merck & Co.
The City With the highest HIV/AIDS Rates in the US
Insider Monkey via Yahoo Finance· 8 hours agoWe recently compiled a list of 20 Cities With the Highest HIV/AIDS Rates in the US and in this article, we will talk about the city with the highest...
In Brief This Week: Delfi Diagnostics, EPrep, Agilent, Angle, MGI Tech, GeneDx, More
GenomeWeb News· 10 hours agoDelfi Diagnostics this week said that the Merck Global Health Innovation Fund, the venture capital arm of Merck & Co., has invested in Delfi to help the ...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 4 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 4 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster...
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 1 day agoCG Oncology, Inc. (NASDAQ: CGON), a biopharmaceutical company engaged in the development of oncology...
ASMS 2024: MOBILion mass spectrometry platform in spotlight
Medical Device Network via Yahoo Finance· 13 hours agoWith capabilities such as lipid nanoparticle (LNP) impurity analysis and peptide drug analysis, the...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 5 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...